Biological Significance of the Bloom's Syndrome Protein
|ClinicalTrials.gov Identifier: NCT00021437|
Recruitment Status : Completed
First Posted : July 13, 2001
Last Update Posted : June 24, 2005
|Condition or disease|
Although an occasional person with BS will be admitted to the hospital for special study (endocrine evaluation mainly)--two in the last 25 years--the Registry does not develop a doctor/patient relationship with affected persons. They have their own doctors. We gather information about the affected persons and publish reports. We also publish reports of experiments carried out in the research laboratory using BS cells. Because we are a central repository for information on BS, families or their physicians find contact with us beneficial, and we provide them with information requested. Sometimes pregnancies at risk occur, and we have on occasion made cytogenic (chromosome) analysis of cultured cells of amniotic fluid (the cultures being initiated elsewhere and sent to us for cytogenetic study).
Although the accessioning of new cases to the Registry was closed in 1991, 4-5 new patients are referred to us each year, and their clinical courses also are being followed. To date, the 169 officially registered and 36 additional cases are under our surveillance.
|Study Type :||Observational|
|Observational Model:||Defined Population|
|Observational Model:||Natural History|
|Official Title:||Biological Significance of the Bloom's Syndrome Protein|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00021437
|United States, New York|
|New York Hospital-Cornell Medical Center|
|New York, New York, United States, 10021|